Previously Funded Researchers

Mohamed Abazeed, M.D., Ph.D.

Cleveland Clinic Foundation

Mapping and Exploiting the Subclonal Architecture of Lung Adenocarcinoma

Mohamed Abdel-Mohsen, PhD

The Wistar Institute

Role of Fungal Translocation in Modulating Post-acute Sequelae of COVID-19

Swarnali Acharyya, PhD

The Trustees of Columbia University in the City of New York

Targeting Brain Relapse in Lung Cancer

Mario Acunzo, PhD

Virginia Commonwealth University

Using New Technologies to Examine Molecular Mechanisms of Lung Cancer Drug Resistance

Dennis Adeegbe, Ph.D.

H. Lee Moffitt Cancer Center & Research Institute

Boosting Immune Activity in the Fight Against Non-Small Cell Lung Cancer

John Aitchison, PhD

Seattle Children's Hospital

Identifying Nanobody Proteins to Neutralize COVID-19 Viruses

Ayobami Akenroye, MB ChB, MPH, PhD

Brigham and Women’s Hospital

Metabolomic Profiles of Patients with Severe Asthma on Inhaled Corticosteroids and on Omalizumab

Ayobami Akenroye, MBChB, MPH, PhD

Brigham and Women’s Hospital, Inc.

Matching the Right Patient to the Right Medicine in Allergic and Eosinophilic Asthma

Gheath Alatrash, DO, PhD

University of Texas M.D. Anderson Cancer Center

Can CAR-T Cell Therapy Be Used to Treat Lung Cancer?

George Alba, MD

Massachusetts General Hospital/Harvard University

Pulmonary Endothelial NEDD9 and Acute Lung Injury

John Albeck, Ph.D.

University of California, Davis

Learning How the Body Repairs Damaged Lung Epithelium

Mehdi Alilou

Case Western Reserve University

Novel Nodule Vessel Features to Predict Response to Lung Cancer Therapies

Teresa Allende-Aydillo Gomez, PhD

Icahn School of Medicine at Mount Sinai

Immunological Imprinting and Cross-reactive Immune Responses in COVID19

Mona Alotaibi, MBBS

The Regents of the University of California, San Diego

Metabolomics Determinants of Post-Acute Sequelae of COVID-19

Vikas Anathy, PhD

The University of Vermont and State Agricultural College

Exploring Role of Cellular Structure That Engulfs Particles in How Lung Cells Control Flu

Kerri Aronson, MD

Joan & Sanford I. Weill Medical College of Cornell University

Improving Patients’ Knowledge About Hypersensitivity Pneumonitis

Elnaz Atabakhsh, Ph.D.

Massachusetts General Hospital

Gene Mutation Makes Lung Cancer Less Responsive to Treatment

Vincent Auyeung, MD, PhD

University of California, San Francisco

Why Do Transitional Cells Promote Scarring in Pulmonary Fibrosis?

Karim Bahmed, Ph.D.

Temple University

Protecting Alveolar Cells in Emphysema

Steven Baker, PhD

Lovelace Respiratory Research Institute

Alternative Splicing in Human Lung Cells During Influenza A Virus Infection

Audreesh Banerjee, M.D.

University of Pennsylvania

How Class of Drugs Decreases Airway Hyperresponsiveness

Riyue Bao, PhD

UPMC Hillman Cancer Center, University of Pittsburgh

Tumor Cell Signaling May Impact Immunotherapy Response for Lung Squamous Cell Cancer

Xiaoyong Bao, Ph.D.

University of Texas Medical Branch

Developing Vaccine Against Virus That Can be Deadly in Children

Xiaoyong Bao, PhD

University of Texas Medical Branch at Galveston

Targeting Protein That Regulates SARS-CoV-2 Could Lead to Better COVID-19 Treatments

Alan P. Baptist, MD, MPH

University of Michigan

Evaluating Behavioral Intervention to Improve Asthma in Older Adults

Pankaj Baral, PhD

Kansas State University

Neuroimmune Regulation of Influenza A Infection and Viral Pneumonia

Joseph Barbi, Ph.D.

Roswell Park Cancer Institute

Will Blocking a Nerve Protein Help Stop Lung Tumor Growth?

Christina Barkauskas, MD

Duke University

Testing Tapeworm Drug Against COVID-19 Virus

R. Graham Barr, MD, DrPH

The Trustees of Columbia University in NYC

The Collaborative Cohort of Cohorts for COVID-19 Research (C4R) CT Study

Juliana Barreto de Albuquerque, PhD

Massachusetts General Hospital

Enhancing Immunity Against Respiratory Pathogens Through Mucosal Vaccination